Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
GLP-1 treatments may be appropriate for patients who have struggled to lose weight through diet, exercise, or other medications alone especially when factors like insulin resistance, metabolic slowdown, or appetite dysregulation are involved
Tesamorelin was developed under the brand name Egrifta and received FDA approval for reducing excess visceral fat in HIV-associated lipodystrophy, making it one of the few GHRH analogs with both clinical trial data and regulatory approval behind it
Operating in Hampton, Virginia, Klinic focuses solely on branded, FDA-regulated medications like Wegovy, ensuring quality, consistent dosing, and trustworthy clinical data, eliminating the need for compounded alternatives
No shortcuts, no compromises
This is not inherently a problem
